Bill Title: Providing for consideration of the bill (H.B. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.B. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2018-03-20 - Motion to reconsider laid on the table Agreed to without objection. [HR787 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Engrossed	2018-03-22	PDF	Link	View
Introduced	2018-03-20	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HR787

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HR787 currently on file.

Social Comments on US HR787